Pharmaceutical Industry Articles & Reports - Page 14

Explore cloud-based regulatory submission tools for pharma. This guide covers eCTD software, RIM systems, compliance (21 CFR Part 11), benefits, and challenges.

Learn how to prepare a Health Canada eCTD submission. This guide covers mandatory requirements, the CESG gateway, validation rules, and the REP process for drug

Compare SaaS vs. on-premise eCTD solutions for pharma. This guide analyzes TCO, scalability, GxP compliance (21 CFR Part 11), and security for both models.

An overview of regulatory submission software for the life sciences. Learn how RIM systems & eCTD publishing tools streamline compliant filings to the FDA & EMA

Learn how to choose eCTD software for small pharma. This guide covers regulatory compliance, global submission timelines for FDA & EMA, and eCTD v4.0 updates.

Learn the most common eCTD validation errors that cause Refuse-to-File (RTF) actions. This guide covers structural, XML, and PDF issues for successful submissio

Learn best practices for managing eCTD submissions. This guide covers the eCTD structure, publishing tools, QC processes, and how to avoid common technical erro

Learn the key differences between the Common Technical Document (CTD) and electronic CTD (eCTD). This guide covers the evolution from paper to the XML-based eCT

Learn the complete eCTD publishing process for regulatory submissions. Updated May 2026 with the latest eCTD v4.0 milestones (PMDA mandate Apr 2026, EMA optional Dec 2025, FDA voluntary, ANVISA 2026).

A complete guide to the IND & NDA eCTD submission process. Learn the eCTD format, CTD modules, FDA requirements, and the transition from eCTD v3.2.2 to v4.0.

Updated May 2026: in-depth comparison of eCTD software for regulatory submissions, analyzing top platforms (LORENZ/MasterControl, Veeva, EXTEDO, Certara) on features, pricing, and eCTD v4.0 readiness.

Learn about eCTD regional variations for global regulatory submissions. This guide compares Module 1 requirements from the FDA, EMA, Health Canada, and more.

Learn the EMA eCTD Gateway specifications for regulatory submissions. This guide explains the technical architecture, AS2 protocols, validation, and file requir

Updated May 2026: Learn about common eCTD validation errors that lead to submission rejection. Covers FDA and EMA rules, eCTD v4.0 rollout, Health Canada Validation Rules v5.3, and strategies for first-pass compliance.

Learn the FDA's mandatory eCTD submission requirements, including key deadlines, technical standards, and the transition from eCTD v3.2.2 to v4.0 for NDAs, BLAs

A guide to regulatory submission quality control (QC). Explore best practices for eCTD dossier checklists to ensure compliance and avoid costly FDA/EMA rejectio

Learn the essential eCTD validation requirements for regulatory submissions to the FDA and EMA. This guide covers technical specifications, business rules, and

Learn the technical requirements for eCTD software submissions to the FDA, EMA, and Health Canada. Updated May 2026 with the latest eCTD v4.0 mandates including Japan's April 2026 cutover.

Learn how integrating eCTD publishing software with a Document Management System (DMS) streamlines pharma regulatory submissions and improves data consistency. Updated May 2026 with FDA eCTD v4.0 voluntary program status and EMA's 2026–2027 v4.0 transition timeline.

A technical guide to eCTD publishing software for regulatory submissions. Compare top tools like LORENZ, EXTEDO, and Veeva for eCTD v4.0 compliance and validati

Explore key strategies for accelerating pharma regulatory submissions. Learn about expedited pathways, process redesign, and the role of AI in shortening drug a

Learn what eCTD viewer software is and why it's critical for regulatory submissions. This guide covers key features, technical capabilities, and tools.

Learn how Regulatory Information Management (RIM) systems help biotech firms manage compliance. This guide details core capabilities, submission planning, and t

Explore key challenges in pharmaceutical regulatory submissions, from legacy eCTD issues and CMC gaps to the rise of AI and structured data for faster drug appr